Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 platform study evaluating novel immunotherapy combinations in previously untreated, advanced/metastatic non-small cell lung cancer; …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Tumor Treating Fields for Locally Advanced NSCLC [Phase 1]
A Phase 1 clinical trial evaluating Tumor Treating Fields for locally advanced non-small cell lung cancer is currently recruiting at the Uni…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
Update on a clinical trial evaluating the combination of osimertinib with chemotherapy as first-line therapy for EGFR mutation-positive non-…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
A clinical trial led by the European Institute of Oncology is investigating molecular phenotyping of primary lung cancer and its metastatic …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial is evaluating niraparib plus pembrolizumab versus placebo plus pembrolizumab as maintenance therapy in adults with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) [Phase 2]
A pilot Phase II clinical trial is evaluating maintenance cabozantinib plus pembrolizumab for metastatic squamous non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas [Phase 2]
A Phase 2 clinical trial of TVB-2640 in KRAS-mutant non-small cell lung cancer is listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Integrated Molecular Profiling in Advanced Cancers Trial
An ongoing trial, Integrated Molecular Profiling in Advanced Cancers, sponsored by University Health Network in Toronto, investigates using …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors [NA]
This entry reports a recruiting clinical trial evaluating urolithin A in patients with previously untreated solid tumors receiving immune ch…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
A clinical trial funded by Elephas is exploring a biomarker-based method to predict response to immunotherapy using live tumor biopsies; the…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients [Phase 3]
Phase 3 study of Ivonescimab for first-line treatment of metastatic non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance [Phase 2]
A Phase 2 clinical trial evaluating the combination of carboplatin, a taxane, and ramucirumab for patients with non-small cell lung cancer a…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy [Phase 2, Phase 3]
A Phase 2/3 trial is evaluating high-dose dexamethasone to reduce postoperative pain after video-assisted thoracoscopic surgery lobectomy/se…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy [Phase 1, Phase 2]
This clinical trial evaluates the combination of tocilizumab and atezolizumab in adults with locally advanced or metastatic non-small cell l…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas [Phase 1]
DR-0202 is being studied in a Phase 1 trial across multiple locally advanced or metastatic carcinomas; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC [Phase 2]
Taletrectinib is being studied in a Phase 2 global trial for ROS1-positive non-small cell lung cancer, with the study currently active but n…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification [Phase 2]
Phase 2 trial of osimertinib combined with savolitinib for non-small cell lung cancer with MET amplification; currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase II trial update investigating the combination of encorafenib and binimetinib in Chinese patients with metastatic non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer [Phase 2]
A Phase 2 neoadjuvant trial is investigating sacituzumab tirumotecan with limertinib for potentially resectable stage III EGFR-mutant non-sm…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations [Phase 3]
An ongoing Phase 3 clinical trial comparing datopotamab deruxtecan plus pembrolizumab versus pembrolizumab alone as first-line treatment for…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II) [Phase 4]
This clinical trial update describes an ongoing post-operative radiotherapy study for non-small cell lung cancer with N2 metastases in the i…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants [Phase 1]
A Phase 1 study evaluating BAT3306 compared with pembrolizumab (Keytruda) in patients with non-small cell lung cancer is currently recruitin…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Effects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung Cancer [NA]
A clinical trial evaluating a visual interactive LINE chatbot to help patients with non-small cell lung cancer self-manage EGFR-TKI related …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC
This clinical trial update describes the PEMBRO-K study evaluating therapeutic pharmacological monitoring with pembrolizumab in non-small ce…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC [Phase 1]
Phase 1 clinical trial evaluating neoadjuvant therapy for resectable non-small cell lung cancer using a combination of NK-cell therapy, a PD…